Related Experiment Video
Updated: Jul 11, 2026
05:31
Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Differences in developing intestinal microbiota between allergic and non-allergic infants: a pilot study in Japan
Prapa Songjinda1, Jiro Nakayama, Atsushi Tateyama
1Department of Bioscience and Biotechnology, Faculty of Agriculture, Graduate School, Kyushu University, 6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan.
Bioscience, Biotechnology, and Biochemistry
|September 11, 2007
Summary
Infant gut microbiome analysis revealed higher Bacteroidaceae populations in allergic infants at 1 and 2 months. This early difference in gut bacteria may be linked to allergy development in children.
Area of Science:
- Microbiology
- Pediatrics
- Immunology
Background:
- The infant gut microbiome plays a crucial role in immune system development.
- Early life gut bacterial composition is increasingly linked to the risk of developing allergies.
- Understanding these early microbial patterns can inform allergy prevention strategies.
Purpose of the Study:
- To investigate the association between early-life fecal bacterial composition and allergy development in Japanese infants.
- To quantify specific predominant bacterial groups in the infant gut during the first two months of life.
Main Methods:
- Real-time PCR was used to quantify six predominant bacterial groups: Bacteroidaceae, Enterobacteriaceae, bifidobacteria, enterococci, lactobacilli, and Clostridium perfringens group.
- Fecal samples were collected from 15 infants for the first 2 months of life.
- Bacterial populations were compared between infants who developed allergies and those who did not by age 2 years.
Main Results:
- A significantly higher population of Bacteroidaceae was observed in infants who developed allergies compared to non-allergic infants at both 1 month (P=0.03) and 2 months (P=0.05) of age.
- No statistically significant differences were found in the populations of Enterobacteriaceae, bifidobacteria, enterococci, lactobacilli, or the Clostridium perfringens group between the allergic and non-allergic groups.
Conclusions:
- Elevated levels of Bacteroidaceae in early infancy may be a potential biomarker for allergy development.
- Further research is needed to elucidate the causal relationship between Bacteroidaceae and infant allergies.
- Targeting specific gut bacteria in early life could be a future avenue for allergy prevention.
Related Concept Videos
01:30Development of Human Microbiota
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
01:23Anatomy of the Intestines
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the small...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:22Introduction to the Human Microbiota
Microorganisms colonize various regions of the human body, including the mouth, nasal passages, throat, stomach, intestines, urogenital tract, and skin. The total number of microbial cells is estimated to range from 10¹³ to 10¹⁴—comparable to, or exceeding, the number of human somatic cells. This host–microbiome relationship has led to the conceptualization of humans as supraorganisms, wherein microbial communities perform vital roles in development, immunity, and disease...
01:27Microbiota of the Stomach and Small Intestine
The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...